Erythema Multiforme Induced by Secukinumab: Clinical, Dermoscopic, and Histological Features
J Clin Rheumatol
.
2021 Aug 1;27(5):e177-e178.
doi: 10.1097/RHU.0000000000001315.
Authors
Claudio Conforti
1
,
Damiano Currado
2
,
Roberta Vezzoni
1
,
Paola Corneli
1
,
Rosanna Bussani
3
,
Luca Navarini
2
,
Giovanni Magaton-Rizzi
1
,
Fabio Fischetti
4
,
Nicola Di Meo
1
,
Iris Zalaudek
1
Affiliations
1
From the Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste.
2
Unit of Allergology, Clinical Immunology and Rheumatology, Università Campus Bio-Medico di Roma, Rome.
3
Institute of Pathological Anatomy.
4
Department of Rheumatology, University of Trieste, Cattinara Hospital, Trieste, Italy.
PMID:
31977648
DOI:
10.1097/RHU.0000000000001315
No abstract available
MeSH terms
Antibodies, Monoclonal, Humanized*
Erythema Multiforme* / chemically induced
Erythema Multiforme* / diagnosis
Humans
Substances
Antibodies, Monoclonal, Humanized
secukinumab